Metformin in polycystic ovary syndrome: Systematic review and meta-analysis

British Medical Journal

Volumn 327, Issue 7421, 2003, Pages 951-955

  Lord, Jonathan M ^a   Flight, Ingrid H K ^b   Norman, Robert J ^c  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b CSIRO   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CLOMIFENE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; FERTILITY PROMOTING AGENT; LIPID;

ANOVULATION; BLOOD PRESSURE REGULATION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; INSULIN BLOOD LEVEL; LONG TERM CARE; META ANALYSIS; MULTIPLE PREGNANCY; NAUSEA; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SPONTANEOUS ABORTION; TREATMENT OUTCOME; VOMITING; BLOOD; BLOOD PRESSURE; BODY WEIGHT; DOUBLE BLIND PROCEDURE; FEMALE; OVULATION; PREGNANCY; SINGLE BLIND PROCEDURE; STATISTICS;

BLOOD PRESSURE; BODY WEIGHT; DOUBLE-BLIND METHOD; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INSULIN; LIPIDS; METFORMIN; OVULATION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; RANDOMIZED CONTROLLED TRIALS; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 0142247208     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Hull MGR. Epidemiplogy of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gyn Endocrinol 1987;1:233-45.
2. Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries - a common finding in normal women. Lancet 1988;1;870-2.
3. Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol Oxf 1999;51:779-86.
4. Legro RS. Diabetes prevalence and risk factors in polycystic ovary syndrome. Obstet Gynecol Clin North Am 2001;28:99-109.
5. Fleming R, Hopkinson ZE, Wallace AM, Greer IA, Sattar N. Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J Clin Endocrinol Metab 2002;87:569-74.
6. Jakubowicz DJ, Seppala M, Jakubowicz S, Rodriguez-Armas O, Rivas-Santiago A, Koistinen H, et al. Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in die polycystic ovary syndrome. J Clin Endocrinol Metab 2001;86:1126-33.
7. Kocak M, Caliskan E, Simsir C, Haberal A. Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril 2002;77:101-6.
8. Malkawi HY, Qublan HS. The effect of metformin plus clomiphene citrate on ovulation and pregnancy rates in clomiphene-resistant women with polycystic ovary syndrome. Saudi Med J 2002;23:663-6.
9. Moghetti P, Casrello R, Negri C, Tosi F, Perrone F, Caputo M, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 2000;85:139-46.
10. Ng EHY, Wat NMS, Ho PC. Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: A randomized, double-blinded placebo-controlled trial. Hum Reprod 2001;16:1625-31.
11. Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 2000;85:2767-74.
12. Sturrock ND, Lannon B, Fay TN. Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice. Br J Clin Pharmacol 2002;53:469-73.
13. Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW, Nestler JE. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril 2001;75:310-5.
14. Yarali H, Yildiz BO, Demirol A, Zeyneloglu HB, Yigit N, Bukulmez O, et al. Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial. Hum Reprod 2002;17:289-94.
15. Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 1996;335:617-23.
16. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998;338:1876-80.
17. El-Biely MM, Habba M. The use of metformin to augment the induction of ovulation in obese infertile patients with polycystic ovary syndrome. Middle East Fertil Soc J 2001;6:43-9.
18. Kousta E, White DM, Franks S. Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update 1997;3:359-65.
19. Messinis IE, Milingos SD. Current and future status of ovulation induction in polycystic ovary syndrome. Hum Reprod Update 1997;3:235-53.
20. Hague WM, Davoren PM, Oliver J, Rowan J. Contraindications to use of metformin. Metformin may be useful in gestational diabetes. BMJ 2003;326:762.
21. Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod 1998;13:1502-5.
22. Royal College of Obstetrics and Gynaecology. Evidence-based clinical guideline No. 2: the initial investigation and management of the infertile couple. London: RCOG Press, 1998.
23. Norman RJ, Davies MJ, Lord J, Moran LJ. The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab 2002;13:251-7.
24. Nestler JE. Metformin and the polycystic ovary syndrome. J Clin Endocrinol Metab 2001;86:1430.
25. Royal College of Obstetrics and Gynaecology. Evidence-based clinical guidelines No. 3: the management of infertility in secondary care. London: RCOG Press, 1998
26. Royal College of Obstetrics and Gynaecology. Long-term consequences of polycystic ovary syndrome. London, RCOG, 2003, (Clinical Green Top Guideline No 33.)